PSS13 COST-EFFECTIVE ANALYSIS OF PEGAPTANIB (MACUGEN®) AS COMPARED WITH RANIBIZUMAB (LUCENTIS®) FOR TREATING IN AGE-RELATED MACULAR DEGENERATION (AMD)

✍ Scribed by LY Lu; W McGhan

• Book ID: 118609602
• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 68 KB
• Volume: 11
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)70908-6